Medical

Professionals collaborating on a project

At Our Core

Olympus Sponsors MedTech Color 2022 Pitch Competition

On March 8, 2022, Olympus Corporation of the Americas had the honor of sponsoring a hybrid event featuring live pitches from the top 10 finalists of competing med-tech organizations all with the same goal: to get their early-stage medical technology innovation funded. The MedTech Color 2022 Pitch Competition, an inspired event via MedTech Color, served as a catalyst for early-stage med-tech companies founded or led by persons of color to present their medical innovations for awards ranging from $100K - $250K in non-dilutive funding and in-kind services.

Medical Technologies

Lung Cancer Screenings: Raising Rates and Awareness

Lung cancer is the second most common cancer among men and women, and the leading cause of cancer death in the United States. Yet, studies show an alarmingly low rate of participation among those who are eligible for lung cancer screenings.

Medical Technologies

Prove It: The Value of Healthcare Economics in the Medical Device Industry

Olympus Director of Health Economics and Reimbursement, Beth Wall, RN, MS, shared findings of the economic value of an investment in ENDOCUFF VISION technology with the Journal of Healthcare Purchasing.

Research Round-Up

Urine Trouble: Uncovering Patient Understanding of an Enlarged Prostate

Despite the prevalence of Benign Prostatic Hyperplasia, many men lack awareness about prostate health and are reluctant to seek valuable treatment. Olympus conducted a consumer survey to learn more about their awareness and understanding.

At Our Core

4 Stories That Will Change Your Mind About Avoiding Your Colonoscopy

A recent survey uncovered 4 major reasons as to why they would avoid colorectal cancer screening. As this preventable disease continues to impact our communities, Olympus is eager to dispel these common myths of colorectal cancer screenings to combat its prevalence.

Investor Information Olympus Responds to COVID-19